Investment Analysts’ Recent Ratings Changes for Ryan Specialty (RYAN)

A number of research firms have changed their ratings and price targets for Ryan Specialty (NYSE: RYAN):

• 4/13/2026 – Ryan Specialty had its price target lowered by Mizuho from $44.00 to $42.00. They now have a “neutral” rating on the stock.
• 4/9/2026 – Ryan Specialty had its price target lowered by JPMorgan Chase & Co. from $49.00 to $43.00. They now have an “underweight” rating on the stock.
• 4/9/2026 – Ryan Specialty had its price target lowered by Wells Fargo & Company from $56.00 to $42.00. They now have an “overweight” rating on the stock.
• 4/9/2026 – Ryan Specialty had its price target lowered by Cantor Fitzgerald from $45.00 to $40.00. They now have a “neutral” rating on the stock.
• 4/8/2026 – Ryan Specialty had its price target lowered by UBS Group AG from $65.00 to $59.00. They now have a “buy” rating on the stock.
• 4/8/2026 – Ryan Specialty had its price target lowered by Barclays PLC from $45.00 to $41.00. They now have an “overweight” rating on the stock.
• 4/8/2026 – Ryan Specialty had its price target lowered by The Goldman Sachs Group, Inc. from $57.00 to $49.00. They now have a “buy” rating on the stock.
• 4/7/2026 – Ryan Specialty had its price target lowered by Keefe, Bruyette & Woods from $55.00 to $49.00. They now have an “outperform” rating on the stock.
• 4/6/2026 – Ryan Specialty had its price target lowered by Morgan Stanley from $55.00 to $50.00. They now have an “overweight” rating on the stock.
• 3/23/2026 – Ryan Specialty had its price target lowered by Citigroup Inc. from $60.00 to $55.00. They now have a “buy” rating on the stock.
• 3/17/2026 – Ryan Specialty is now covered by Royal Bank Of Canada. They set an “outperform” rating and a $45.00 price target on the stock.
• 3/11/2026 – Ryan Specialty had its price target lowered by Barclays PLC from $52.00 to $45.00. They now have an “overweight” rating on the stock.
• 2/27/2026 – Ryan Specialty had its price target lowered by Mizuho from $53.00 to $44.00. They now have a “neutral” rating on the stock.
• 2/25/2026 – Ryan Specialty was downgraded by BMO Capital Markets from “outperform” to “market perform”. They now have a $43.00 price target on the stock, down from $66.00.
• 2/24/2026 – Ryan Specialty was downgraded by Zacks Research from “hold” to “strong sell”.
• 2/23/2026 – Ryan Specialty had its price target lowered by Morgan Stanley from $61.00 to $55.00. They now have an “overweight” rating on the stock.
• 2/17/2026 – Ryan Specialty had its price target lowered by UBS Group AG from $71.00 to $65.00. They now have a “buy” rating on the stock.
• 2/17/2026 – Ryan Specialty had its price target lowered by Cantor Fitzgerald from $52.00 to $45.00. They now have a “neutral” rating on the stock.
• 2/13/2026 – Ryan Specialty was given a new $53.00 price target by Mizuho.
• 2/13/2026 – Ryan Specialty had its price target lowered by Piper Sandler from $58.00 to $43.00. They now have a “neutral” rating on the stock.
• 2/13/2026 – Ryan Specialty had its price target lowered by Barclays PLC from $58.00 to $52.00. They now have an “overweight” rating on the stock.
• 2/13/2026 – Ryan Specialty had its price target lowered by Keefe, Bruyette & Woods from $65.00 to $55.00. They now have an “outperform” rating on the stock.
• 2/13/2026 – Ryan Specialty had its price target lowered by Wells Fargo & Company from $63.00 to $56.00. They now have an “overweight” rating on the stock.

Ryan Specialty Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 10th. Shareholders of record on Tuesday, February 24th were issued a $0.13 dividend. This is a boost from Ryan Specialty’s previous quarterly dividend of $0.12. The ex-dividend date was Tuesday, February 24th. This represents a $0.52 annualized dividend and a yield of 1.5%. Ryan Specialty’s payout ratio is presently 123.81%.

Insiders Place Their Bets

In other Ryan Specialty news, Director Patrick G. Ryan, Jr. purchased 25,500 shares of the business’s stock in a transaction on Monday, February 23rd. The stock was bought at an average cost of $39.96 per share, for a total transaction of $1,018,980.00. Following the acquisition, the director owned 428,295 shares of the company’s stock, valued at approximately $17,114,668.20. The trade was a 6.33% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at this link. Company insiders own 52.03% of the company’s stock.

Ryan Specialty Group, Inc (NYSE: RYAN) is a global specialty insurance and reinsurance platform that partners with a network of insurers and reinsurers to deliver tailored risk solutions. The company focuses on complex and large-scale risks across multiple industry sectors, leveraging its underwriting expertise to structure coverage programs that meet clients’ unique needs.

Ryan Specialty’s core offerings span a diverse range of specialty lines, including casualty, property, professional liability, marine and energy, program administration, and sports and entertainment.